aluates Reports

$ 0.0

Automative

Interferon Beta-1a - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-18F3203

Global Interferon Beta 1a Market Insights and Forecast to 2026

BUY CHAPTERS

Interferon Beta-1a - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18F3203

Report

September 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Cinnagen

Merck KGaA

TEVA

Novartis

Bayer

Sanofi

Acorda Therapeutics

Mallinckrodt plc

Interferon Beta-1a - Market Size

The global market for Interferon Beta-1a was estimated to be worth US$ 4324 million in 2023 and is forecast to a readjusted size of US$ 2584.8 million by 2030 with a CAGR of -7.1% during the forecast period 2024-2030

Interferon Beta-1a - Market

Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.

Interferon Beta-1a is a medication used for the treatment of relapsing forms of multiple sclerosis (MS). The market for Avonex is driven by factors such as the increasing prevalence of MS, the growing awareness about the disease, and advancements in MS treatment. Avonex is a well-established therapy with a proven track record of efficacy and safety. The market is also influenced by factors such as healthcare infrastructure development, favorable reimbursement policies, and the availability of generic alternatives. However, the market faces challenges such as competition from other MS treatments and the introduction of newer therapies. Despite these challenges, Avonex continues to hold a significant market share due to its established reputation and effectiveness. As research and development in the field of MS continue, the Avonex market is expected to witness moderate growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Interferon Beta-1a, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Interferon Beta-1a by region & country, by Type, and by Application.

The Interferon Beta-1a market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interferon Beta-1a.

Market Segmentation

Scope of Interferon Beta-1a - Market Report

Report Metric	Details
Report Name	Interferon Beta-1a - Market
Forecasted market size in 2030	US$ 2584.8 million
Forecasted years	2024 - 2030
Segment by Type:	Subcutaneous Intramuscular
Segment by Application	Hospital Drugs Store Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, CinnaGen, Merck KGaA, Teva, Novartis, Bayer, Sanofi, Acorda Therapeutics, Mallinckrodt
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Interferon Beta-1a manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Interferon Beta-1a in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Interferon Beta-1a in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Interferon Beta-1a - Market size in 2030?

Ans: The Interferon Beta-1a - Market size in 2030 will be US$ 2584.8 million.

Who are the main players in the Interferon Beta-1a - Market report?

Ans: The main players in the Interferon Beta-1a - Market are Biogen, CinnaGen, Merck KGaA, Teva, Novartis, Bayer, Sanofi, Acorda Therapeutics, Mallinckrodt

What are the Application segmentation covered in the Interferon Beta-1a - Market report?

Ans: The Applications covered in the Interferon Beta-1a - Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Interferon Beta-1a - Market report?

Ans: The Types covered in the Interferon Beta-1a - Market report are Subcutaneous, Intramuscular

Recommended Reports

Neurological Diseases

Pharmaceutical APIs

Infectious Diseases

1 Market Overview

1.1 Interferon Beta-1a Product Introduction

1.2 Global Interferon Beta-1a Market Size Forecast

1.2.1 Global Interferon Beta-1a Sales Value (2019-2030)

1.2.2 Global Interferon Beta-1a Sales Volume (2019-2030)

1.2.3 Global Interferon Beta-1a Sales Price (2019-2030)

1.3 Interferon Beta-1a Market Trends & Drivers

1.3.1 Interferon Beta-1a Industry Trends

1.3.2 Interferon Beta-1a Market Drivers & Opportunity

1.3.3 Interferon Beta-1a Market Challenges

1.3.4 Interferon Beta-1a Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Interferon Beta-1a Players Revenue Ranking (2023)

2.2 Global Interferon Beta-1a Revenue by Company (2019-2024)

2.3 Global Interferon Beta-1a Players Sales Volume Ranking (2023)

2.4 Global Interferon Beta-1a Sales Volume by Company Players (2019-2024)

2.5 Global Interferon Beta-1a Average Price by Company (2019-2024)

2.6 Key Manufacturers Interferon Beta-1a Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Interferon Beta-1a Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Interferon Beta-1a

2.9 Interferon Beta-1a Market Competitive Analysis

2.9.1 Interferon Beta-1a Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Interferon Beta-1a Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interferon Beta-1a as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Subcutaneous

3.1.2 Intramuscular

3.2 Global Interferon Beta-1a Sales Value by Type

3.2.1 Global Interferon Beta-1a Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Interferon Beta-1a Sales Value, by Type (2019-2030)

3.2.3 Global Interferon Beta-1a Sales Value, by Type (%) (2019-2030)

3.3 Global Interferon Beta-1a Sales Volume by Type

3.3.1 Global Interferon Beta-1a Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Interferon Beta-1a Sales Volume, by Type (2019-2030)

3.3.3 Global Interferon Beta-1a Sales Volume, by Type (%) (2019-2030)

3.4 Global Interferon Beta-1a Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Drugs Store

4.1.3 Other

4.2 Global Interferon Beta-1a Sales Value by Application

4.2.1 Global Interferon Beta-1a Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Interferon Beta-1a Sales Value, by Application (2019-2030)

4.2.3 Global Interferon Beta-1a Sales Value, by Application (%) (2019-2030)

4.3 Global Interferon Beta-1a Sales Volume by Application

4.3.1 Global Interferon Beta-1a Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Interferon Beta-1a Sales Volume, by Application (2019-2030)

4.3.3 Global Interferon Beta-1a Sales Volume, by Application (%) (2019-2030)

4.4 Global Interferon Beta-1a Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Interferon Beta-1a Sales Value by Region

5.1.1 Global Interferon Beta-1a Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Interferon Beta-1a Sales Value by Region (2019-2024)

5.1.3 Global Interferon Beta-1a Sales Value by Region (2025-2030)

5.1.4 Global Interferon Beta-1a Sales Value by Region (%), (2019-2030)

5.2 Global Interferon Beta-1a Sales Volume by Region

5.2.1 Global Interferon Beta-1a Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Interferon Beta-1a Sales Volume by Region (2019-2024)

5.2.3 Global Interferon Beta-1a Sales Volume by Region (2025-2030)

5.2.4 Global Interferon Beta-1a Sales Volume by Region (%), (2019-2030)

5.3 Global Interferon Beta-1a Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Interferon Beta-1a Sales Value, 2019-2030

5.4.2 North America Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Interferon Beta-1a Sales Value, 2019-2030

5.5.2 Europe Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Interferon Beta-1a Sales Value, 2019-2030

5.6.2 Asia Pacific Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Interferon Beta-1a Sales Value, 2019-2030

5.7.2 South America Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Interferon Beta-1a Sales Value, 2019-2030

5.8.2 Middle East & Africa Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Interferon Beta-1a Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Interferon Beta-1a Sales Value

6.2.1 Key Countries/Regions Interferon Beta-1a Sales Value, 2019-2030

6.2.2 Key Countries/Regions Interferon Beta-1a Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Interferon Beta-1a Sales Value, 2019-2030

6.3.2 United States Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Interferon Beta-1a Sales Value, 2019-2030

6.4.2 Europe Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Interferon Beta-1a Sales Value, 2019-2030

6.5.2 China Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.5.3 China Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Interferon Beta-1a Sales Value, 2019-2030

6.6.2 Japan Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Interferon Beta-1a Sales Value, 2019-2030

6.7.2 South Korea Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Interferon Beta-1a Sales Value, 2019-2030

6.8.2 Southeast Asia Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Interferon Beta-1a Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Interferon Beta-1a Sales Value, 2019-2030

6.9.2 India Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

6.9.3 India Interferon Beta-1a Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Biogen

7.1.1 Biogen Company Information

7.1.2 Biogen Introduction and Business Overview

7.1.3 Biogen Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Biogen Interferon Beta-1a Product Offerings

7.1.5 Biogen Recent Development

7.2 CinnaGen

7.2.1 CinnaGen Company Information

7.2.2 CinnaGen Introduction and Business Overview

7.2.3 CinnaGen Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CinnaGen Interferon Beta-1a Product Offerings

7.2.5 CinnaGen Recent Development

7.3 Merck KGaA

7.3.1 Merck KGaA Company Information

7.3.2 Merck KGaA Introduction and Business Overview

7.3.3 Merck KGaA Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Merck KGaA Interferon Beta-1a Product Offerings

7.3.5 Merck KGaA Recent Development

7.4 Teva

7.4.1 Teva Company Information

7.4.2 Teva Introduction and Business Overview

7.4.3 Teva Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Teva Interferon Beta-1a Product Offerings

7.4.5 Teva Recent Development

7.5 Novartis

7.5.1 Novartis Company Information

7.5.2 Novartis Introduction and Business Overview

7.5.3 Novartis Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Novartis Interferon Beta-1a Product Offerings

7.5.5 Novartis Recent Development

7.6 Bayer

7.6.1 Bayer Company Information

7.6.2 Bayer Introduction and Business Overview

7.6.3 Bayer Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bayer Interferon Beta-1a Product Offerings

7.6.5 Bayer Recent Development

7.7 Sanofi

7.7.1 Sanofi Company Information

7.7.2 Sanofi Introduction and Business Overview

7.7.3 Sanofi Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Sanofi Interferon Beta-1a Product Offerings

7.7.5 Sanofi Recent Development

7.8 Acorda Therapeutics

7.8.1 Acorda Therapeutics Company Information

7.8.2 Acorda Therapeutics Introduction and Business Overview

7.8.3 Acorda Therapeutics Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Acorda Therapeutics Interferon Beta-1a Product Offerings

7.8.5 Acorda Therapeutics Recent Development

7.9 Mallinckrodt

7.9.1 Mallinckrodt Company Information

7.9.2 Mallinckrodt Introduction and Business Overview

7.9.3 Mallinckrodt Interferon Beta-1a Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Mallinckrodt Interferon Beta-1a Product Offerings

7.9.5 Mallinckrodt Recent Development

8 Industry Chain Analysis

8.1 Interferon Beta-1a Industrial Chain

8.2 Interferon Beta-1a Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Interferon Beta-1a Sales Model

8.5.2 Sales Channel

8.5.3 Interferon Beta-1a Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Biogen

Cinnagen

Merck KGaA

TEVA

Novartis

Bayer

Sanofi

Acorda Therapeutics

Mallinckrodt plc

List of Tables

Table 1. Interferon Beta-1a Market Trends

Table 2. Interferon Beta-1a Market Drivers & Opportunity

Table 3. Interferon Beta-1a Market Challenges

Table 4. Interferon Beta-1a Market Restraints

Table 5. Global Interferon Beta-1a Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Interferon Beta-1a Revenue Market Share by Company (2019-2024)

Table 7. Global Interferon Beta-1a Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Interferon Beta-1a Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Interferon Beta-1a Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Interferon Beta-1a Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Interferon Beta-1a Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Interferon Beta-1a

Table 13. Global Interferon Beta-1a Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interferon Beta-1a as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Interferon Beta-1a Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Interferon Beta-1a Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Interferon Beta-1a Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Interferon Beta-1a Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Interferon Beta-1a Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Interferon Beta-1a Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Interferon Beta-1a Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Interferon Beta-1a Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Interferon Beta-1a Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Interferon Beta-1a Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Interferon Beta-1a Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Interferon Beta-1a Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Interferon Beta-1a Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Interferon Beta-1a Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Interferon Beta-1a Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Interferon Beta-1a Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Interferon Beta-1a Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Interferon Beta-1a Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Interferon Beta-1a Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Interferon Beta-1a Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Interferon Beta-1a Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Interferon Beta-1a Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Interferon Beta-1a Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Interferon Beta-1a Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Interferon Beta-1a Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Interferon Beta-1a Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Interferon Beta-1a Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Interferon Beta-1a Sales Value by Region (2019-2024) & (%)

Table 44. Global Interferon Beta-1a Sales Value by Region (2025-2030) & (%)

Table 45. Global Interferon Beta-1a Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Interferon Beta-1a Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Interferon Beta-1a Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Interferon Beta-1a Sales Volume by Region (2019-2024) & (%)

Table 49. Global Interferon Beta-1a Sales Volume by Region (2025-2030) & (%)

Table 50. Global Interferon Beta-1a Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Interferon Beta-1a Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Interferon Beta-1a Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Interferon Beta-1a Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Interferon Beta-1a Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Interferon Beta-1a Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Interferon Beta-1a Sales Volume, (2025-2030) & (K Units)

Table 57. Biogen Company Information

Table 58. Biogen Introduction and Business Overview

Table 59. Biogen Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Biogen Interferon Beta-1a Product Offerings

Table 61. Biogen Recent Development

Table 62. CinnaGen Company Information

Table 63. CinnaGen Introduction and Business Overview

Table 64. CinnaGen Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CinnaGen Interferon Beta-1a Product Offerings

Table 66. CinnaGen Recent Development

Table 67. Merck KGaA Company Information

Table 68. Merck KGaA Introduction and Business Overview

Table 69. Merck KGaA Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Merck KGaA Interferon Beta-1a Product Offerings

Table 71. Merck KGaA Recent Development

Table 72. Teva Company Information

Table 73. Teva Introduction and Business Overview

Table 74. Teva Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Teva Interferon Beta-1a Product Offerings

Table 76. Teva Recent Development

Table 77. Novartis Company Information

Table 78. Novartis Introduction and Business Overview

Table 79. Novartis Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Novartis Interferon Beta-1a Product Offerings

Table 81. Novartis Recent Development

Table 82. Bayer Company Information

Table 83. Bayer Introduction and Business Overview

Table 84. Bayer Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Bayer Interferon Beta-1a Product Offerings

Table 86. Bayer Recent Development

Table 87. Sanofi Company Information

Table 88. Sanofi Introduction and Business Overview

Table 89. Sanofi Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Sanofi Interferon Beta-1a Product Offerings

Table 91. Sanofi Recent Development

Table 92. Acorda Therapeutics Company Information

Table 93. Acorda Therapeutics Introduction and Business Overview

Table 94. Acorda Therapeutics Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Acorda Therapeutics Interferon Beta-1a Product Offerings

Table 96. Acorda Therapeutics Recent Development

Table 97. Mallinckrodt Company Information

Table 98. Mallinckrodt Introduction and Business Overview

Table 99. Mallinckrodt Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Mallinckrodt Interferon Beta-1a Product Offerings

Table 101. Mallinckrodt Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Interferon Beta-1a Downstream Customers

Table 105. Interferon Beta-1a Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Interferon Beta-1a Product Picture

Figure 2. Global Interferon Beta-1a Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Interferon Beta-1a Sales Volume (2019-2030) & (K Units)

Figure 5. Global Interferon Beta-1a Sales Price (2019-2030) & (USD/Unit)

Figure 6. Interferon Beta-1a Report Years Considered

Figure 7. Global Interferon Beta-1a Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Interferon Beta-1a Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Interferon Beta-1a Revenue in 2023

Figure 10. Interferon Beta-1a Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Subcutaneous Picture

Figure 12. Intramuscular Picture

Figure 13. Global Interferon Beta-1a Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Interferon Beta-1a Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Interferon Beta-1a Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Interferon Beta-1a Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Interferon Beta-1a Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Drugs Store

Figure 20. Product Picture of Other

Figure 21. Global Interferon Beta-1a Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Interferon Beta-1a Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Interferon Beta-1a Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Interferon Beta-1a Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Interferon Beta-1a Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Interferon Beta-1a Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Interferon Beta-1a Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Interferon Beta-1a Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Interferon Beta-1a Sales Volume (%), (2019-2030)

Figure 38. United States Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 44. China Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 46. China Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 56. India Interferon Beta-1a Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Interferon Beta-1a Sales Value by Type (%), 2023 VS 2030

Figure 58. India Interferon Beta-1a Sales Value by Application (%), 2023 VS 2030

Figure 59. Interferon Beta-1a Industrial Chain

Figure 60. Interferon Beta-1a Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Glatiramer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Glatiramer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Glatiramer Acetate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global β Interferon Market Research Report 2024

Multiple Sclerosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peginterferon Injection Market Research Report 2024

Interferon Beta Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Interferon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2030

Global Hepatitis C Interferon Market Research Report 2024

Avonex Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global α Interferon Market Research Report 2024

Global Short acting Human Interferon α2a Market Research Report 2024

Recombinant Interferon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Interferons Market Research Report 2024

Global Short acting Interferon Injection Market Research Report 2024

Gilenya Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Multiple Sclerosis Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Interferon Injection Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions